Stockreport

Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind [Yahoo! Finance]

60 Degrees Pharmaceuticals, Inc.  (SXTP) 
PDF The study will be the world's first clinical trial to evaluate tafenoquine in human babesiosis patients Enrollment will begin after a site initiation visit in Boston [Read more]